A promising new targeted cancer therapy is now available to certain patients with advanced pancreatic cancer – from the comfort of their home. The treatment is available through a first-of-its-kind, ...

According to DataM Intelligence AUSTIN, Texas and TOKYO, Nov. 18, 2025 /PRNewswire/ -- DataM Intelligence announces the latest insights into the rapidly transforming Oncology Molecular Diagnostics ...

As of Monday, November 10, Cogent Biosciences, Inc.’s COGT share price has surged by 136.17%, which has investors questioning if this is right time to sell.

Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of ...

Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: ...

Gomekli showed an 87% overall response rate in pediatric low-grade glioma with MAPK pathway activation, with a recommended ...

Cogent Biosciences, Inc. stock soars after bezuclastinib's strong Phase 3 results in GIST. Click for my updated look at COGT stock and why I am bullish.

Detailed price information for Cogent Biosciences Inc (COGT-Q) from The Globe and Mail including charting and trades.

DataM Intelligence announces the latest insights into the rapidly transforming Oncology Molecular Diagnostics Market, which increased ...

The bacteria Acinetobacter baumannii (A. baumannii)is a haunting presence in many hospitals in the United States, where more than one in 100 patients are treated for A. baumannii infections. This ...

Primary central nervous system (CNS) tumors pose significant challenges due to their heterogeneous nature, frequently limited prognosis, and substantial impact on quality of life. Despite advances in ...